Germitec Raises €29 Million Series B for Expansion
Deal News | Feb 13, 2025 | Goodwin
Germitec, a MedTech company known for UV-C High-Level Disinfection solutions, recently raised €29 million in a Series B financing round. The investment was led by Eurazeo's Nov Sant Actions Non Cotes fund, with participation from existing investors Kurma Partners, Financiere Arbevel, and Turenne Capital. Operating out of Bordeaux, Germitec has gained international recognition in ultrasound probe disinfection, currently serving over 40 countries. The firm is looking to expand further, having obtained FDA De Novo certification in the United States for its product, Chronos. The legal advisory for this financing was provided by Goodwin, with a team that included Anne-Charlotte Rivire, Sonia Sassi, Ines Louguar for corporate matters, and Marie Fillon for intellectual property aspects.
Sectors
- MedTech
- Healthcare
Geography
- France – Germitec is based in Bordeaux, France and is a key player in the French MedTech sector.
- United States – Germitec is expanding into the U.S. market with FDA clearance for its Chronos product.
- Europe – Eurazeo's fund focuses on developing healthcare sectors across Europe, relevant as this round was led by them.
Industry
- MedTech – Germitec operates in the MedTech industry, focusing on innovative healthcare solutions like UV-C High-Level Disinfection systems.
- Healthcare – The funding round supports Germitec's expansion in healthcare global markets, especially with their disinfection technology.
Financials
- €29 Million – The amount raised by Germitec in the Series B financing round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Germitec | Target | Company | A MedTech company specializing in UV-C disinfection technology, leading global markets in probe disinfection. |
| Eurazeo | Lead Investor | Company | A private equity firm managing the Nov Sant Actions Non Cotes fund, leading the Series B round for Germitec. |
| Goodwin | Legal Advisor | Company | Provided legal advice to Germitec on the Series B financing round. |
| Kurma Partners | Investor | Company | An existing investor participating in Germitec’s Series B round. |
| Financiere Arbevel | Investor | Company | An existing investor participating in Germitec’s Series B round. |
| Turenne Capital | Investor | Company | An existing investor participating in Germitec’s Series B round. |
| Anne-Charlotte Rivière | Legal Advisor - Corporate | Person | Member of Goodwin’s team handling corporate aspects of Germitec’s financing. |
| Sonia Sassi | Legal Advisor - Corporate | Person | Member of Goodwin’s team handling corporate aspects of Germitec’s financing. |
| Ines Louguar | Legal Advisor - Corporate | Person | Member of Goodwin’s team handling corporate aspects of Germitec’s financing. |
| Marie Fillon | Legal Advisor - IP | Person | Member of Goodwin’s team handling intellectual property aspects of Germitec’s financing. |